Visualizing fronto-striatal circuitry and neuroleptic effects in schizophrenia

Acta Psychiatrica Scandinavica, Supplement

Volumn 99, Issue 395, 1999, Pages 129-137

  Buchsbaum, Monte S ^a   Hazlett, E A ^a   Haznedar, M M ^a   Spiegel Cohen, J ^a   Wei, T C ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Deoxyglucose; Neuroleptics; Prefrontal cortex

Indexed keywords

HALOPERIDOL; NEUROLEPTIC AGENT;

BRAIN MAPPING; BRAIN METABOLISM; CAUDATE NUCLEUS; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; CORPUS STRIATUM; DIAGNOSTIC IMAGING; DRUG EFFECT; DRUG MECHANISM; FEMALE; FRONTAL LOBE; HUMAN; LEARNING; MALE; NERVE CELL NETWORK; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; SCHIZOPHRENIA; TASK PERFORMANCE; THALAMUS; ADULT; AGED; ARTICLE; CASE CONTROL STUDY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; IMAGE PROCESSING; METABOLISM; MIDDLE AGED; NERVE TRACT; PHYSIOLOGY; PREFRONTAL CORTEX; PROBABILITY; SCINTISCANNING;

ADULT; AGED; ANTIPSYCHOTIC AGENTS; BRAIN MAPPING; CASE-CONTROL STUDIES; CAUDATE NUCLEUS; CORPUS STRIATUM; FEMALE; FRONTAL LOBE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEURAL PATHWAYS; PREFRONTAL CORTEX; PROBABILITY; SCHIZOPHRENIA; TOMOGRAPHY, EMISSION-COMPUTED; VERBAL LEARNING;

EID: 0032616040     PISSN: 00651591     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (63)

1. PENNY JB, YOUNG AB. Speculations on the functional anatomy of basal ganglia dysfunction. Annu Rev Neurosci 1983;6:73-94.
2. ALEXANDER GE, DELONG MR, STRICK PL. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci 1986;9:357-81.
3. CROSSON B, HUGHES CW. Role of the thalamus in language: is it related to thought disorder? Schizophr Bull 1987;13:605-621.
4. BRAFF DL, GRILLON C, GEYER MA. Gating and habituation of the startle reflex in schizophrenic patients. Arch Gen Psychiatry 1992;49:206-215.
5. SWERDLOW NR, KOOB GF. Dopamine, schizophrenia, mania, and depression: toward a unified hypothesis of cortico-striato-pallido-thalamic function. Behav Brain Sci 1987;10:197-245.
6. WEINBERGER DR. A connectionist approach to the prefrontal cortex. J Neuropsychiatry Clin Neurosci 1993;5:241-253.
7. BUCHSBAUM MS, HAZLETT EA. Positron emission tomography studies of abnormal glucose metabolism in schizophrenia. Schizophr Bull 1998;24:343-364.
8. INGVAR DH, FRANZÈN G. Abnormalities of cerebral blood flow distribution in patients with chronic schizophrenia. Acta Psychiatr Scand 1974;50:425-462.
9. BUCHSBAUM MS, INGVAR DH, KESSLER R et al. Cerebral glucography with positron tomography: use in normal subjects and in patients with schizophrenia. Arch Gen Psychiatry 1982;39:251-259.
10. 10. FARKAS T, WOLF AP, JAEGER J et al. Regional brain glucose metabolism in chronic schizophrenia: a positron emission transaxial tomographic study. Arch Gen Psychiatry 1984;41:293-300.
11. WILLIAMSON P. Hypofrontality in schizophrenia: a review of the evidence. Can J Psychiatry 1987;32:399-404.
12. BUCHSBAUM MS. The frontal lobes, basal ganglia, and temporal lobes as sites for schizophrenia. Schizophr Bull 1990;16:377-387.
13. ANDREASEN NC, REZAI K, ALLIGER R et al. Hypofrontality in neuroleptic-naive patients and in patients with chronic schizophrenia. Arch Gen Psychiatry 1992;49:943-958.
14. CHUA SE, McKENNA PJ. Schizophrenia - a brain disease? A critical review of structural and functional cerebral abnormality in the disorder. Br J Psychiatry 1995;166:563-582.
15. 2 receptor density estimates in schizophrenia: a positron emission tomography study with 11-C-N-methylspiperone. Psychiatry Res 1993;49:219-237.
16. SEEMAN P. Brain dopamine receptors. Pharmacol Rev 1980;32:229-313.
17. BUCHSBAUM M, HAIER R, POTKIN S et al. Frontostriatal disorder of cerebral metabolism in never-medicated schizophrenics. Arch Gen Psychiatry 1992;49:935-942.
18. TALAIRACH J, TOURNOUX P. Co-planar stereotaxic atlas of the human brain. New York: Thieme Medical Publishers, 1988.
19. MATSUI T, HIRANO A. An atlas of the human brain for computerized tomography. Tokyo: Igaku-Shoin, 1978.
20. BUCHSBAUM MS, WU J, DELISI L et al. Positron emission tomography studies of basal ganglia and somatosensory cortex neuroleptic drug effects: differences between normal controls and schizophrenic patients. Biol Psychiatry 1987;22:479-494.
21. COHEN RM, SEMPLE WE, GROSS M et al. The effect of neuroleptics on dysfunction in a prefrontal substrate of sustained attention in schizophrenia. Life Sci 1988;43:1141-1150.
22. WIK G, WIESEL FA, SJÖGREN I et al. Effects of sulpiride and chlorpromazine on regional cerebral glucose metabolism in schizophrenic patients as determined by positron emission tomography. Psychopharmacology 1989;97:309-318.
23. CLEGHORN JM, SZECHTMAN H, GARNETT ES et al. Neuroleptic effects on regional brain metabolism in first-episode schizophrenics. Schizophr Res 1991;5:208-209.
24. CLEGHORN JM, ZIPURSKY RB, LIST SJ. Structural and functional brain imaging in schizophrenia. J Psychiatry Neurosci 1991;16:53-74.
25. BUCHSBAUM MS, POTKIN S, MARSHALL JF et al. Effects of clozapine and thiothixene on glucose metabolic rate in schizophrenia. Neuropsychopharmacology 1992;6:155-163.
26. BUCHSBAUM M, POTKIN S, SIEGEL B et al. Striatal metabolic rate and clinical response to neuroleptics in schizophrenia. Arch Gen Psychiatry 1992;49:966-974.
27. POTKIN SG, BUCHSBAUM MS, JIN Y. Clozapine effects on glucose metabolic rate in striatum and frontal cortex. J Clin Psychiatry 1994;55(Suppl B):63-66.
28. HOLCOMB JJ, CASCELLA NG, THANKER GK, MEDOFF DR, DANNALS RF, TAMMINGA CA. Functional sites of neuroleptic drug action in the human brain: PET/FDG studies with and without haloperidol. Am J Psychiatry 1996:153:41-49.
29. BARTLETT EJ, BRODIE JD, SIMKOWITZ P et al. Time-dependent effects of a haloperidol challenge on energy metabolism in the normal human brain. Psychiatry Res 1996;66:91-99.
30. WOLKIN A, SANFILIPO M, DUNCAN E et al. Blunted change in cerebral glucose utilization after haloperidol treatment in schizophrenic patients with prominent negative symptoms. Am J Psychiatry 1996;153:346-354.
31. RESNICK SM, GUR RE, ALAVI A et al. Positron emission tomography and subcortical glucose metabolism in schizophrenia. Psychiatry Res 1988;24:1-11.
32. BARTLETT EJ, WOLKIN A, BRODIE, JD, LASKA EM, WOLF AP. Importance of pharmacologic control in PET studies: effects of thiothixene and haloperidol on cerebral glucose utilization in chronic schizophrenia. Psychiatry Res Neuroimaging 1991;40:115-124.
33. 33. BUCHSBAUM MS, HAZLETT E, GUPTA A et al. Positron emission tomography in schizophrenics treated with atypical and typical neuroleptics. Proceedings of the Sixth World Congress of Biological Psychiatry, Nice, France, 22-27 June 1997.
34. COHEN RM, NORDAHL TE, SAMPLE WF, ANDREASON P, LITMAN RE, PICKAR D. The brain metabolic patterns of clozapine- and fluphenazine-treated patients with schizophrenia during a continuous performance task. Arch Gen Psychiatry 1997;54:481-486.
35. BUCHSBAUM MS, SOMEYA T, TENG CY et al. PET and MRI of the thalamus in never-medicated patients with schizophrenia. Am J Psychiatry 1996;153:191-199.
36. FRISTON KJ, FRITH CD, LIDDLE PF, FRACKOWIAK RSJ. Functional connectivity: the principal-component analysis of large (PET) data sets. J Cereb Blood Flow Metab 1993;13:5-14.
37. FRISTON KJ, LIDDLE PF, FRITH CD, HIRSCH SR, FRACKOWIAK RSJ. The left medial temporal region and schizophrenia. Brain 1992;115:367-382.
38. SZABO Z, CAMARGO EE, SOSTRE, S et al. Factor analysis of regional cerebral glucose metabolic rates in healthy men. Eur J Nuel Med 1992;19:469-475.
39. SCHRÖDER J, BUCHSBAUM MS, SIEGEL BV et al. Patterns of cortical activity in schizophrenia. Psychol Med 1994;24:947-955.
40. SCHRÖDER J, BUCHSBAUM MS, SIEGEL BV, GEIDER FJ, NIETHAMMER R. Structural and functional correlates of subsyndromes in chronic schizophrenia. Psychopathology 1995;28:38-45.
41. SCHRÖDER J, BUCHSBAUM MS, SIEGEL BV et al. Cerebral metabolic activity correlates of subsyndromes in chronic schizophrenia. Schizophr Res 1996;19:41-53.
42. CLARK CM, KESSLER R, BUCHSBAUM MS, MARGOLIN RA, HOLCOMB HH. Correlational methods for determining regional coupling of cerebral glucose metabolism: a pilot study. Biol Psychiatry 1984;19:663-678.
43. KESSLER RM, CLARK CM, BUCHSBAUM MS et al. Regional correlations in patterns of glucose use in patients with schizophrenia and normal subjects during mild pain stimulation. In: HEISS WD, PHELPS MD, ed. Positron emission tomography of the brain. Berlin: Springer Verlag, 1983:196-200.
44. WU JC, SIEGEL BV, HAIER RJ, BUCHSBAUM MS. Testing the Swerdlow/Koob model of schizophrenia pathophysiology using positron emission tomography. Behav Brain Sci 1990;13:169-170.
45. 45. KATZ M, BUCHSBAUM MS, SIEGEL BV, WU J, HAIER RJ, BUNNEY WE. Correlational patterns of cerebral glucose metabolism in never-medicated schizophrenics. Neuropsychobiology 1996;33:1-11.
46. HORWITZ B. Simulating functional interactions in the brain: a model for examining correlations between regional cerebral metabolic rates. Int J Biomed Comput 1990;26:149-170.
47. HORWITZ B, SWEDO SE, GRADY CL et al. Cerebral metabolic pattern in obsessive-compulsive disorder: altered intercorrelations between regional rates of glucose utilization. Psychiatry Res Neuroimaging 1991;40:221-237.
48. METTER J, RIEGE WH, HANSON WR, JACKSON CA, KEMPLER D, LANCKER DV. Subcortical structures in aphasia: an analysis based on (F-18)-fluorodeoxyglucose, positron emission tomography, and computed tomography. Arch Neurol 1988;45:1229-1234.
49. WIESEL FA, WIK G, SJÖGREN I, BLOMQVIST G, GREITZ T. Altered relationships between metabolic rates of glucose in brain regions of schizophrenic patients. Acta Psychiatr Scand 1987;76:642-647.
50. VOLKOW VD, WOLF AP, BRODIE JD et al. Brain interactions in chronic schizophrenics under resting and activation conditions. Schizophr Res 1988;1:47-53.
51. BAXTER LR, BRODY A, SAXENA S, SCHWARTZ J, ACKERMANN R. Specific brain systems in obsessive-compulsive disorder treatment. Eur Neuropsychopharmacol 1996;6 (Suppl. 3):91.
52. SWERDLOW NR, KOOB GF. Authors' response. Behav Brain Sci 1990;13:172-175.
53. ANDREASEN NC, FLAUMM, ARNDT S. The Comprehensive Assessment of Symptoms and History (CASH): an instrument for assessing diagnosis and psychopathology. Arch Gen Psychiatry 1992;49:615-623.
54. OVERALL JE, GORHAM DR. The Brief Psychiatric Rating Scale. Psychol Rep 1962;10:799-812.
55. National Institute of Mental Health. Abnormal Involuntary Movements Scale developed by the Psychopharmacology Branch. In: GUY W, ed. ECDEU assessment manual for psychopharmacology, revised. Washington, DC: US Government Printing Office, 1976.
56. DELIS DC, KRAMER JH, KAPLAN E, OBER BA. The California Verbal Learning Test. San Antonio, TX: Psychological Corporation, 1987.
57. BATTIG MA, MONTAGUE F. Handbook of semantic word norms. Hillsdale, NJ: Lawrence Erlbaum, 1981.
58. PELIZZARI CA, CHEN GTY, SPELBRING DR, WEICHSELBAUM RR, CHEN CT. Accurate three-dimensional registration of CT, PET and/or MR images of the brain. J Comput Assist Tomogr 1989;13:20-26.
59. SELEMON LD, GOLDMAN-RAKIC PS. Longitudinal topography and interdigitation of corticostriatal projections in the Rhesus monkey. J Neurosci 1985;5:776-794.
60. POLINEJ B, MAZOYER BM. Analysis of individual positron emission tomography activation maps by detection of high signal-to-noise-ratio pixel clusters. J Cereb Blood Flow Metab 1993;13:425-437.
61. 15O-butanol brain activation images. Hum Brain Mapping 1993;1:3-19.
62. SHIHABUDDIN L, BUCHSBAUM MS, HAZLETT EA et al. Striatal size, shape, and metabolic rate in neuroleptic-naive and previously medicated schizophrenic patients performing a verbal learning task. Arch Gen Psychiatry 1998;55:235-243.
63. MCINTOSH AR, GONZALES-LIMA F. Structural modeling of functional neural pathways mapped with 2-deoxyglucose: effects of acoustic startle habituation on the auditory system. Brain Res 1991;547:295-302.